Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity (Tables)

v3.26.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Summary of Share-Based Compensation Expense The following table sets forth share-based compensation expense included in the consolidated statements of operations:

 

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

Cost of revenue

 

$

131

 

 

$

112

 

Research and development

 

 

2,017

 

 

 

1,641

 

Sales and marketing

 

 

2,224

 

 

 

1,881

 

General and administrative

 

 

3,808

 

 

 

3,273

 

Share-based compensation expense

 

$

8,180

 

 

$

6,907

 

 

Share-based compensation expense by type of share-based award:

 

Year Ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

Stock options

 

$

272

 

 

$

653

 

RSAs and RSUs

 

 

7,647

 

 

 

6,066

 

ESPP

 

 

261

 

 

 

188

 

 

$

8,180

 

 

$

6,907

 

 

 

Total unrecognized compensation expense by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized (in thousands, unless otherwise noted):

 

 

December 31, 2025

 

 

Unrecognized
Expense

 

 

Remaining
Weighted-
Average
Recognition
Period (in years)

 

Stock options

 

$

28

 

 

 

0.18

 

RSAs and RSUs

 

$

8,479

 

 

 

1.72

 

Summary of Stock Option Activity

Stock option activity under all of the Company’s Plans as of and for the year ended December 31, 2025 is summarized below:

 

 

Stock
Options

 

 

Weighted-
average
Exercise
price
per share

 

 

Weighted-
average
Remaining
Contractual
Life (in years)

 

 

Intrinsic
Value
(in thousands)
(1)

 

Outstanding at December 31, 2024

 

 

1,376,396

 

 

$

6.48

 

 

 

 

 

 

 

Exercised

 

 

(38,013

)

 

$

5.98

 

 

 

 

 

 

 

Forfeited or expired

 

 

(36,311

)

 

$

32.15

 

 

 

 

 

 

 

Outstanding at December 31, 2025

 

 

1,302,072

 

 

$

5.78

 

 

 

3.80

 

 

$

10,809

 

Exercisable at December 31, 2025

 

 

1,259,605

 

 

$

5.70

 

 

 

3.68

 

 

$

10,572

 

Vested and expected to vest at December 31, 2025

 

 

1,302,072

 

 

$

5.78

 

 

 

3.80

 

 

$

10,809

 

 

(1)
Intrinsic value is calculated as the estimated fair value of the Company’s stock at December 31, 2025 less the option exercise price of in-the-money options.
Summary of Non-vested Stock Options

A summary of the status of the Company’s non-vested stock options for the year ended December 31, 2025 is presented below:

 

 

Non-vested Stock
Options

 

 

Weighted-
Average
Grant
Date Fair Value

 

Nonvested, December 31, 2024

 

 

123,987

 

 

$

6.83

 

Vested

 

 

(81,520

)

 

$

7.26

 

Nonvested, December 31, 2025

 

 

42,467

 

 

$

6.00

 

Summary of Fair Value Assumptions

The fair value of the purchase options under the ESPP are estimated at the beginning of the purchase period using the Black-Scholes valuation model utilizing the following assumptions:

 

 

2025

 

2024

Risk-free interest rate

 

4.25% -4.29%

 

5.24% - 5.37%

Expected life (in years)

 

0.5

 

0.5

Estimated volatility

 

77.32% - 84.49%

 

64.5% - 67.33%

Expected dividends

 

None

 

None

Schedule of Restricted Stock Activity

RSA activity as of and for the year ended December 31, 2025 is summarized below (no RSAs were granted in 2025 or 2024):

 

 

Restricted Stock
Awards

 

 

Weighted-
Average
Grant
Date Fair Value

 

Outstanding at December 31, 2024

 

 

154,210

 

 

$

11.12

 

Vested

 

 

(152,457

)

 

$

11.12

 

Forfeited or expired

 

 

(1,753

)

 

$

11.41

 

Outstanding at December 31, 2025

 

 

 

 

$

 

 

RSU activity as of and for the year ended December 31, 2025 is summarized below:

 

 

Restricted Stock
Units

 

 

Weighted-
Average
Grant
Date Fair Value

 

Outstanding at December 31, 2024

 

 

1,657,760

 

 

$

6.76

 

Granted

 

 

639,617

 

 

$

13.34

 

Vested

 

 

(620,493

)

 

$

7.10

 

Forfeited or expired

 

 

(25,017

)

 

$

8.01

 

Outstanding at December 31, 2025

 

 

1,651,867

 

 

$

9.16